Shashank S. Sinha, MD, FACC

Shashank S. Sinha, MD, FACC

Professional Bio:

Shashank S. Sinha, MD, MSc, serves as Director of the Cardiac Intensive Care Unit and Director of the Cardiovascular Critical Care Research Program at INOVA Fairfax Hospital. He is also a cardiologist within the Advanced Heart Failure, Mechanical Circulatory Support, and Cardiac Transplantation program. Dr. Sinha received his undergraduate degree, cum laude in Applied Mathematics, from Harvard College and his medical degree, with honors, from the University of Chicago Pritzker School of Medicine. He was selected to the Alpha Omega Alpha and Gold Humanism Honor Societies and received the Pritzker Leadership Award. He completed his internship and residency in internal medicine at the University of Pennsylvania, earning the Maurice F. Attie Senior Resident Teaching Award. During his residency training, he completed the inaugural two-year certificate program in Healthcare Leadership in Quality at the University of Pennsylvania. He subsequently served as a medical intensive care unit hospitalist at Penn Presbyterian Medical Center. He matriculated to the University of Michigan, where he completed his clinical fellowship training in cardiovascular disease and advanced heart failure and transplant cardiology. Dr. Sinha also completed a two-year research fellowship and Master’s program in Health and Health Care Research at the University of Michigan Institute for Healthcare Policy and Innovation. The primary focus of his research is to understand and improve the quality of care for patients experiencing cardiac critical illness, including cardiac arrest, cardiogenic shock, and acute decompensated heart failure. He has authored nearly 40 publications in top-tier journals including British Medical Journal, JAMA Internal Medicine, JACC, JACC: Heart Failure, Circulation, Circulation: Heart Failure, and Circulation: Cardiovascular Quality and Outcomes. In fact, one of his most recent co-lead author publications in JACC examined disruptive modifications to cardiac critical care delivery during the COVID-19 pandemic, including insights and perspectives from Italy, Spain, UK and New York City. He serves as the Principal Investigator for the Inova Cardiac Intensive Care Unit Registry and co-Principal Investigator for the Inova Cardiogenic Shock Registry. He is also the site Principal Investigator for the multicenter Cardiogenic Shock Working Group (formerly known as the SHOCK 1000 Registry), which examines acute mechanical circulatory support devices in cardiogenic shock. He also serves as the site PI for the Critical Care Cardiology Trials Network (CCCTN), a first-of-its-kind multicenter registry of cardiac critical illness in North America. His leadership contributions include serving as a member of the American College of Cardiology Heart Failure and Transplant Section Leadership Council, Section Editor for the JACC Fellows-in-Training/Early Career Page and as a CME/Social Media Editor for JACC: Heart Failure. Dr. Sinha has also been recognized with the 2017 American Medical Association’s Excellence in Medicine Leadership Award and was inducted into the American College of Cardiology’s Leadership Academy.

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Abiomed(MODEST)

View Full Disclosure